-
Growth hormone-releasing hormone and its analogues in health and disease Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-11-13 Riccarda Granata, Sheila Leone, Xianyang Zhang, Iacopo Gesmundo, Charlotte Steenblock, Renzhi Cai, Wei Sha, Ezio Ghigo, Joshua M. Hare, Stefan R. Bornstein, Andrew V. Schally
-
Autologous stem-cell derived islets — the ultimate frontier in diabetes mellitus? Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-11-11 A. M. James Shapiro
A patient with longstanding type 1 diabetes mellitus has achieved insulin independence for at least 1 year after transplantation of autologous stem cell islets. These cells were differentiated from inducible pluripotent stem cells from adipose tissue and were transplanted into the rectus sheath of the abdominal wall.
-
Macrophages support pancreatic development Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-11-08 Senegal Carty
Engineering pancreatic tissue transplants to treat diabetes mellitus will require knowledge of how different cell types regulate pancreatic development. A study in Cell Stem Cell characterizes the nuclear transcriptome in the second-trimester human fetal pancreas and shows that macrophages support pancreatic endocrine cell differentiation, proliferation and survival in vitro. To investigate whether
-
Highlights from the Joint Irish–UK Endocrine Meeting 2024 Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-11-08 Olivia Tysoe
This October, the first joint meeting between the Irish Endocrine Society (IES) and the British Society for Endocrinology (SfE) was held in Belfast. On the opening morning, Miguel Debono (University of Sheffield) spoke to a packed room about the challenges of managing mild autonomous cortisol secretion. He discussed whether conservative management or adrenalectomy provided the best outcome for patients
-
IL-17 has a role in whole-body homeostasis Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-11-08 Claire Greenhill
The immune system is known to have a circadian rhythm; however, how circadian rhythms might affect immune homeostasis and physiology more broadly is unclear. A new paper now provides evidence that γδ T cells (a type of innate T cell) produce IL-17 in a rhythmic fashion, which is essential for de novo lipogenesis in adipose tissue and influences whole-body homeostasis. To confirm that IL-17A and IL-17F
-
Intricacies and obscurities of non-shivering thermogenesis Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-11-05 Anand Kumar Sharma
Mammalian cellular machinery has evolved to function best at ~37 °C, making maintenance of core body temperature (at ~37 °C) critical for optimal organ function. The physiological importance of thermoregulation has been appreciated for many years, but our mechanistic understanding of the diversity and functioning of thermogenic mechanisms has advanced considerably in the past century. A brief analysis
-
Looking back at the TEDDY study: lessons and future directions Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-11-04 Åke Lernmark, Daniel Agardh, Beena Akolkar, Patricia Gesualdo, William A. Hagopian, Michael J. Haller, Heikki Hyöty, Suzanne Bennett Johnson, Helena Elding Larsson, Edwin Liu, Kristian F. Lynch, Eoin F. McKinney, Richard McIndoe, Jessica Melin, Jill M. Norris, Marian Rewers, Stephen S. Rich, Jorma Toppari, Eric Triplett, Kendra Vehik, Suvi M. Virtanen, Anette-G. Ziegler, Desmond A. Schatz, Jeffrey
-
Our future, we decide: five ways to reform the scientific publication process Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-28 Morten Dall, Katharina Herzog, Antonia Hufnagel, Daniel B. Ibsen, Benjamin Lebiecka-Johansen, Philip M. M. Ruppert, Jessica M. Preston, Pearlyn J. Y. Toh, Christina Yfanti
-
Metformin in gestational diabetes: physiological actions and clinical applications Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-25 Taitum Mason, Simon Alesi, Melinda Fernando, Eszter Vanky, Helena J. Teede, Aya Mousa
-
Limiting the use and misuse of liothyronine in hypothyroidism Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-24 Laszlo Hegedüs, Endre Vezekenyi Nagy, Enrico Papini, Petros Perros
Liothyronine treatment for some patients with hypothyroidism has preoccupied academics, clinicians and patients for decades, and is a controversial topic in thyroidology. Persistent symptoms are at the heart of this discourse and, contrary to scientific evidence, liothyronine use is increasingly common. Aetiologies and interventions beyond thyroid dysregulation and pharmacological approaches must be
-
Modelling human liver disease: from steatotic liver disease to MASH-HCC Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-24 Christian Stoess, Ariel E. Feldstein
-
Publisher Correction: Current understanding of the molecular and cellular pathology of diabetic retinopathy Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-24 David A. Antonetti, Paolo S. Silva, Alan W. Stitt
-
The epidemiology of type 1 diabetes mellitus in older adults Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-24 Dunya Tomic, Jessica L. Harding, Alicia J. Jenkins, Jonathan E. Shaw, Dianna J. Magliano
-
Inflammation and resolution in obesity Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-24 Matúš Soták, Madison Clark, Bianca E. Suur, Emma Börgeson
-
The complex effects of dietary restriction on longevity and health Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-22 Claire Greenhill
Calorie restriction is known to extend lifespan in a wide range of species; however, the effects are variable and findings from animal models are often not applicable to humans, as the calorie restriction regimes are generally difficult to adhere to in the real world. Now, a paper has explored the effects and underlying mechanisms of several different methods of calorie restriction and dietary restriction
-
IGF2-produced microRNA restricts growth via suppression of IGF1 Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-15 Olivia Tysoe
Insulin-like growth factor 1 (IGF1) is a key protein that contributes to control of an organism’s size after birth and during development, whereas IGF2 is the main regulator of growth and body size during fetal development. A study in Cell Reports describes a mechanism by which a microRNA produced from Igf2 regulates IGF1 to suppress growth in mice. The researchers then assessed the effect of miR-483
-
Skeletal stem and progenitor cells in bone physiology, ageing and disease Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-08 Seppe Melis, Dana Trompet, Andrei S. Chagin, Christa Maes
-
Signals from the dorsal motor nucleus of the vagus promote jejunal fat absorption Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-10-08 Senegal Carty
Efferent nerves from the dorsal motor nucleus of the vagus (DMV) connect to the gastrointestinal system and are thought to regulate digestion. The mechanisms by which the DMV controls nutrient absorption are under active investigation. A study published in Nature shows that a subpopulation of DMV neurons controls intestinal dietary fat absorption by modulating microvillus length in the jejunum. The
-
Liver-specific actions of GH and IGF1 that protect against MASLD Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-25 Rhonda D. Kineman, Mercedes del Rio-Moreno, David J. Waxman
-
Control of tuberal hypothalamic development and its implications in metabolic disorders Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-23 Marysia Placzek, Kavitha Chinnaiya, Dong Won Kim, Seth Blackshaw
-
The multifactorial effect of obesity on the effectiveness and outcomes of cancer therapies Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-23 Joanne Lysaght, Melissa J. Conroy
-
Early life factors that affect obesity and the need for complex solutions Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-23 Kylie D. Hesketh, Miaobing Zheng, Karen J. Campbell
-
Brown adipose tissue fights the battle against leukaemia Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-20 Pamela Fischer-Posovszky, Julia Zinngrebe
-
The glymphatic system as a nexus between obesity and neurological diseases Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-20 Bandy Chen, Stephanie Lenck, Jean-Leon Thomas, Marc Schneeberger
-
Effects of diet on atherosclerotic plaque development Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-19 Claire Greenhill
Atherosclerosis-related cardiovascular diseases are a major cause of death globally, and are expected to increase in prevalence with the rising incidence of obesity and type 2 diabetes mellitus. Despite being very common, there are still large knowledge gaps in our understanding of how atherosclerosis develops. Furthermore, most animal models for atherosclerosis rely on the use of a continuous high-fat
-
Female-specific inflammatory signalling exacerbates central nervous system autoimmunity in obesity Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-19 Olivia Tysoe
Multiple sclerosis (MS) targets the myelin sheath of central nervous system (CNS) neurons. MS is initiated by autoreactive CD4+ T cells, and obesity is known be associated with an increased risk of MS, particularly in women. A study in Cell Metabolism now identifies a female-specific mechanism by which obesity increases the risk of MS by promoting a pro-inflammatory T helper 1 (TH1) CD4+ T cell phenotype
-
Skeletal muscle loss and sarcopenia in obesity pharmacotherapy Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-18 David C. D. Hope, Tricia M-M Tan
Pharmacological therapies with incretin-based ‘multi-agonists’ are rapidly advancing the therapeutic landscape for obesity. The loss of skeletal muscle mass with these potent weight-loss agents is emerging as a possible side effect. It is therefore important to determine whether multi-agonists increase the risk of sarcopenia in susceptible patients.
-
The role of DNA damage in diabetic complications Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-12 Varun Kumar, Ali Önder Yildirim, Peter P. Nawroth
-
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-09-03 Alessandro Grattoni, Gregory Korbutt, Alice A. Tomei, Andrés J. García, Andrew R. Pepper, Cherie Stabler, Michael Brehm, Klearchos Papas, Antonio Citro, Haval Shirwan, Jeffrey R. Millman, Juan Melero-Martin, Melanie Graham, Michael Sefton, Minglin Ma, Norma Kenyon, Omid Veiseh, Tejal A. Desai, M. Cristina Nostro, Marjana Marinac, Megan Sykes, Holger A. Russ, Jon Odorico, Qizhi Tang, Camillo Ricordi
-
Neurons in the diagonal band of Broca moderate food intake Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-29 Senegal Carty
Identifying neurological mechanisms that regulate feeding behaviour could help to advance the treatment and prevention of obesity and eating disorders. New research in mice has identified and localized a population of neurons that promotes eating to satiate hunger and reduces the desire to eat simply for pleasure. One subset of these DBBPENK neurons projects from the DBB to the paraventricular nucleus
-
The promising potential of gene therapy for diabetes mellitus Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-29 Stefan R. Bornstein, J. Fraser Wright, Charlotte Steenblock
Gene therapy holds tremendous promise for treating a wide range of hereditary and acquired diseases by delivering exogenous therapeutic nucleotide sequences into specific cells or tissues. Recent advances support the notion that gene therapy could offer a long-term cure for diabetes mellitus, something that current conventional pharmacotherapies cannot achieve.
-
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-27 Ruth T. Casey, Emile Hendriks, Cheri Deal, Steven G. Waguespack, Verena Wiegering, Antje Redlich, Scott Akker, Rathi Prasad, Martin Fassnacht, Roderick Clifton-Bligh, Laurence Amar, Stefan Bornstein, Letizia Canu, Evangelia Charmandari, Alexandra Chrisoulidou, Maria Currás Freixes, Ronald de Krijger, Luisa de Sanctis, Antonio Fojo, Amol J. Ghia, Angela Huebner, Vasilis Kosmoliaptsis, Michaela Kuhlen
Correction to: Nature Reviews Endocrinology https://doi.org/10.1038/s41574-024-01024-5, published online 15 August 2024.
-
The complexity of adipocyte heterogeneity Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-27 Claire Greenhill
It is well known that adipocytes are heterogeneous, and research about how best to identify and categorize adipocyte subclasses is ongoing. Thermogenic adipocytes are generally identified by the presence of UCP1; the futile creatine cycle is also an important thermogenic process in these cells. However, a lack of suitable models — particularly for beige adipose tissue — has stalled research into the
-
New insights into the regulation of GIPR signalling Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-22 Yusman Manchanda, Alejandra Tomas
Two recent studies have unravelled novel modes of glucose-dependent insulinotropic polypeptide receptor (GIPR) signalling regulation. Kizilkaya et al. characterized the effect of changes in β-arrestin 2 coupling with naturally occurring GIPR coding variants, whereas Regmi et al. investigated GIPR expression profiles and functional regulation in adipocytes.
-
Thyroid nodules: diagnosis and management Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-16 Giorgio Grani, Marialuisa Sponziello, Sebastiano Filetti, Cosimo Durante
-
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-15 Ruth T. Casey, Emile Hendriks, Cheri Deal, Steven G. Waguespack, Verena Wiegering, Antje Redlich, Scott Akker, Rathi Prasad, Martin Fassnacht, Roderick Clifton-Bligh, Laurence Amar, Stefan Bornstein, Letizia Canu, Evangelia Charmandari, Alexandra Chrisoulidou, Maria Currás Freixes, Ronald de Krijger, Luisa de Sanctis, Antonio Fojo, Amol J. Ghia, Angela Huebner, Vasilis Kosmoliaptsis, Michaela Kuhlen
-
Microbial hydrogen sulfide hampers L-cell GLP-1 production Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-13 Senegal Carty
The gut microbiota strongly influences digestive and metabolic health. A study recently published in Nature Metabolism reports a link between hydrogen sulfide released by the gut microbiota and GLP-1 production in the intestines. The findings might have implications for treatment and prevention of the metabolic syndrome. To elucidate the mechanism behind this response, the researchers studied interactions
-
Medically not yet explained symptoms in hypothyroidism Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-13 Laszlo Hegedüs, Christina M. Van Der Feltz-Cornelis, Enrico Papini, Endre V. Nagy, Anthony P. Weetman, Petros Perros
-
Combination therapy increases human β-cell mass in vivo Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-08-02 Olivia Tysoe
People with diabetes mellitus have substantially reduced numbers of pancreatic β-cells compared with healthy individuals. Now, a study in Science Translational Medicine demonstrates the efficacy of a dual tyrosine-regulated kinase 1A (DYRK1A) inhibitor treatment combined with a glucagon-like peptide 1 (GLP1) receptor agonist for increasing human β-cell mass in vivo. The researchers transplanted human
-
Endocrine effects of heat exposure and relevance to climate change Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-30 Fadil M. Hannan, Melvin K. S. Leow, Jason K. W. Lee, Sari Kovats, Taha Elajnaf, Stephen H. Kennedy, Rajesh V. Thakker
-
The interactions between energy homeostasis and neurovascular plasticity Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-25 Bandy Chen, Elisa de Launoit, David Meseguer, Cristina Garcia Caceres, Anne Eichmann, Nicolas Renier, Marc Schneeberger
-
CCN3 maintains bone density during lactation Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-23 Claire Greenhill
In female individuals, oestradiol preserves bone mass. However, oestradiol levels drop during lactation, which is also a time when calcium is being removed from the maternal bone. How bone mass is maintained in lactating female individuals has been unclear. A study published in Nature has now identified a new mechanism for maintaining bone mass, which involves brain–bone crosstalk. Next, the researchers
-
The genetics behind age at menarche Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-22 Senegal Carty
The first menstrual period, or menarche, is an important milestone in female sexual maturation. Studies have begun to determine how genetic variation influences age at menarche (AAM), with a large study recently published in Nature Genetics adding considerably to this knowledge base. To study the effect of common genetic variants on AAM, the researchers performed the largest genome-wide association
-
Graves disease: latest understanding of pathogenesis and treatment options Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-22 Giulia Lanzolla, Michele Marinò, Francesca Menconi
-
PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-17 Silvia Marino, Teresita Bellido
-
The challenges of assessing adiposity in a clinical setting Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-15 Emma Börgeson, Saeideh Tavajoh, Stephan Lange, Niels Jessen
-
Post-burn endocrine–immune dynamics and ageing considerations Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-09 Fadi Khalaf, Zachary Ricciuti, Dalia Barayan, Stephanie Wojtowicz-Piotrowski, Marc G. Jeschke
-
Artemisinins as a promising treatment for polycystic ovary syndrome Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-08 Olivia Tysoe
One of the key drivers of polycystic ovary syndrome (PCOS) is androgen excess, which results in symptoms such as metabolic dysfunction, impaired ovulation and endometrial diseases. A new study in Science investigated the potential for artemisinin, an anti-malaria drug derived from Artemisia plants, and its analogues to reduce androgen levels in women with PCOS and improve PCOS symptoms. The researchers
-
A trio of trials on hormone receptor agonists for MASLD Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-07-01 Shimona Starling
A pressing need exists for drugs to treat metabolic dysfunction-associated steatotic liver disease (MASLD, previously referred to as nonalcoholic fatty liver disease). Now, three phase II clinical trials have reported encouraging findings on three different hormone receptor agonist drugs for MASLD. Over the past few years, great progress has been made in treating type 2 diabetes mellitus (T2DM), obesity
-
Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-27 Matthias B. Schulze, Norbert Stefan
-
Progestin production by the gut microbiota Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-26 Claire Greenhill
The gut microbiota has a role in modifying host steroids, but the exact nature of this interaction has been unclear. New research shows that certain organisms in the gut microbiota produce the neurosteroid allopregnanolone (a derivative of progesterone), and also identified the mechanisms of this production. “Steroids are exquisitely potent signalling molecules, but that also means they’re found in
-
The relationship between the gut microbiota and thyroid disorders Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-21 Marian E. Ludgate, Giulia Masetti, Paula Soares
-
Debunking the myths of intermittent fasting Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-19 Krista A. Varady, Shuhao Lin, Vanessa M. Oddo, Sofia Cienfuegos
Despite the mounting evidence supporting the use of intermittent fasting as a safe and effective weight loss intervention, many myths about fasting persist in popular culture. Here, we review some common beliefs about intermittent fasting that are not supported by scientific evidence.
-
Mind the (human-based new approach methodology) gap! Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-19 Denise D. Belsham
The 1980s marked the beginning of the era of molecular biology; the sky was the limit for new technologies using complex genetic constructs to create mouse models for use in every field of science. In particular, the area of endocrinology had a range of novel transgenic mouse models that encompassed knockouts and knockins that enabled the link from a phenotype to specific genes and gene networks to
-
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-18 Cyril Debuysschere, Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, Didier Hober
-
Evidence for somatic mutation screening on aggressive prolactinomas Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-17 Marily Theodoropoulou, Stephan Petersenn, Philippe Chanson, Gerald Raverot
The recent Consensus Statement on the diagnosis and management of prolactin-secreting pituitary adenomas (prolactinomas) drew attention to molecular pathogenetic mechanisms. We comment that somatic screening for SF3B1 hotspot variants in select cases might alert to aggressive tumour behaviour and prompt the timely management and intense follow up of these challenging tumours.
-
Circulating non-coding RNA biomarkers of endocrine tumours Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-17 Henriett Butz, Attila Patócs, Peter Igaz
-
Gut hormones and bone homeostasis: potential therapeutic implications Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-10 Béatrice Bouvard, Guillaume Mabilleau
-
Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-06 Daniela Esposito, Cesar Luiz Boguszewski, Annamaria Colao, Maria Fleseriu, Federico Gatto, Jens Otto Lunde Jørgensen, Oskar Ragnarsson, Diego Ferone, Gudmundur Johannsson
-
Metabolic alliance: pharmacotherapy and exercise management of obesity Nat. Rev. Endocrinol. (IF 31.0) Pub Date : 2024-06-05 Javier Butragueño, Jonatan R. Ruiz